Key result
Combined elevated E/e' and LVH predicts ~165% higher HFpEF rehospitalization risk in stage 3-4 CKD.
Why the study?
Patients with HFpEF and coexisting chronic kidney disease have poor outcomes, and whether a combined echocardiographic indicator could improve risk stratification remained unassessed.
Does a combined echocardiographic indicator (E/e' ≥15 and LVH) improve risk stratification for HFpEF rehospitalization in adults with HFpEF and stage 3-4 CKD?
Cohort (n=254)
No
Does a combined echocardiographic indicator (E/e' ≥15 and LVH) improve risk stratification for HFpEF rehospitalization in adults with HFpEF and stage 3-4 CKD?
Effect estimate: HR 2.65 (95% CI 1.59-4.41)
p-value: p=<0.001
A combined echocardiographic indicator of E/e' ≥15 and LVH improves risk stratification for rehospitalization in patients with HFpEF and stage 3-4 CKD.
May aid HFpEF rehospitalization risk stratification in CKD; hypothesis-generating and requires prospective validation.
Introduction Patients with heart failure with preserved ejection fraction (HFpEF) and coexisting chronic kidney disease (CKD) have poor outcomes. This study assessed whether a combined echocardiographic indicator could improve risk stratification for this high-risk group. Methods In a retrospective study of 254 adults with HFpEF and stage 3–4 CKD, we evaluated an indicator combining elevated E/e' ratio (≥15) and left ventricular hypertrophy (LVH). The primary outcome was rehospitalization for HFpEF. Statistical analyses included Cox regression, C-index, and decision curve analysis. Results Over a 2.1-year median follow-up, 26.8% of patients were rehospitalized. The combined indicator was a strong, independent predictor of this outcome. It demonstrated superior discrimination (C-index 0.74) compared to either E/e' (0.67) or LVH (0.65) alone, showing clinical utility across a range of risk thresholds. Conclusion A combined echocardiographic indicator integrating E/e' and LVMI improves risk stratification in patients with HFpEF and advanced CKD.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) conducted a cohort in Heart failure with preserved ejection fraction (HFpEF) and stage 3-4 chronic kidney disease (CKD) (n=254). Combined echocardiographic indicator (E/e' ratio ≥ 15 and left ventricular hypertrophy) vs. Negative combined indicator was evaluated on First rehospitalization for HFpEF (HR 2.65, 95% CI 1.59-4.41, p=<0.001). A combined echocardiographic indicator of elevated E/e' ratio and left ventricular hypertrophy independently predicted an increased risk of HFpEF rehospitalization (HR 2.65) in patients with stage 3-4 CKD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: